FIELD: medicine. SUBSTANCE: a cryoprotective solution contains hexamethylenebistetraoxyethylurea 24.0-36.0%, sodium fumarate 2.4- 3.2%, citric acid 0.03-0.09% and water for injections - up to 100 ml. The suggested cryoprotective solution provides higher percentage of physiologically valuable cells at freezing leucosuspension up to -50 C. EFFECT: higher efficiency. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
COLD-SAFETY SOLUTION FOR FREEZING LEUKOCYTES AT SUB-MODERATE TEMPERATURE | 2002 |
|
RU2240000C2 |
CRYOPROTECTIVE SOLUTION FOR LEUKOCYTE FREEZING AT LOW TEMPERATURE | 2004 |
|
RU2290808C2 |
COLD-SAFETY SOLUTION FOR FREEZING PLATELETS AT MODERATELY LOW TEMPERATURE | 2002 |
|
RU2230454C2 |
CRYOPROTECTIVE SOLUTION FOR MODERATELY HYPOTHERMIC LEUKOCYTE PRESERVATION (-40°C) | 2009 |
|
RU2439877C2 |
COMBINED CRYOPROTECTIVE SOLUTION FOR THROMBOCYTE FREEZING | 2012 |
|
RU2477953C1 |
PROTECTIVE SOLUTION FOR PRESERVING LEUKOCYTE AT TEMPERATURE -10°C | 2004 |
|
RU2261595C1 |
METHOD FOR CRYOGENIC PRESERVATION OF CELLULAR SUSPENSIONS | 2001 |
|
RU2195111C1 |
AQUEOUS SOLUTION FOR PLATELET CRYOCONSERVATION | 1988 |
|
RU1561227C |
FROST PROTECTION SOLUTION FOR NUCLEAR BLOOD CELL FREEZING | 2011 |
|
RU2464991C1 |
METHOD OF BONE MARROW PRESERVATION | 1998 |
|
RU2144290C1 |
Authors
Dates
2002-07-10—Published
2001-04-18—Filed